Back
VanEck Digital Transformation ETF Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Sell
37
DAPP
VanEck Digital Transformation ETF
Last Price:
$17.09
Seasonality Move:
-16.4%
Sell
39
MNPR
Monopar Therapeutics, Inc.
Last Price:
$71.43
Seasonality Move:
36.18%
Sell
37
VanEck Digital Transformation ETF (DAPP)
is a Sell
Is VanEck Digital Transformation ETF a Buy, Sell or Hold?
-
The current VanEck Digital Transformation ETF [DAPP] share price is $16.82. The Score for DAPP is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
DAPP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $75.12. The Score for MNPR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DAPP Stock Price Chart
What is VanEck Digital Transformation ETF's stock price today?
-
The VanEck Digital Transformation ETF share price today is $16.82Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DAPP is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $75.12Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.
DAPP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.54 | Sell |
| Relative Strength Index (14 RSI): | 36.87 | Sell |
| Chaikin Money Flow: | -801765 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.09 - 19.97) | Sell |
| Bollinger Bands (100): | (17.02 - 23.18) | Sell |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.87 | Sell |
| Relative Strength Index (14 RSI): | 42.12 | Sell |
| Chaikin Money Flow: | -62944 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (76.34 - 86.56) | Sell |
| Bollinger Bands (100): | (44.09 - 88.71) | Buy |
DAPP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.18 | Sell |
| 20-day SMA: | 18.28 | Sell |
| 50-day SMA: | 21.49 | Sell |
| 200-day SMA: | 16.5 | Buy |
| 8-day EMA: | 18.72 | Sell |
| 20-day EMA: | 19.09 | Sell |
| 50-day EMA: | 19.99 | Sell |
| 200-day EMA: | 17.86 | Sell |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 77.09 | Sell |
| 20-day SMA: | 81.11 | Sell |
| 50-day SMA: | 83.94 | Sell |
| 200-day SMA: | 51.58 | Buy |
| 8-day EMA: | 77.09 | Sell |
| 20-day EMA: | 79.63 | Sell |
| 50-day EMA: | 78.25 | Sell |
| 200-day EMA: | 56.2 | Buy |
VanEck Digital Transformation ETF Earnings Growth & DAPP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
VanEck Digital Transformation ETF Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||